Literature DB >> 23121096

Ion channels as therapeutic targets: a drug discovery perspective.

Sharan K Bagal1, Alan D Brown, Peter J Cox, Kiyoyuki Omoto, Robert M Owen, David C Pryde, Benjamin Sidders, Sarah E Skerratt, Edward B Stevens, R Ian Storer, Nigel A Swain.   

Abstract

Ion channels are membrane proteins expressed in almost all living cells. The sequencing of the human genome has identified more than 400 putative ion channels, but only a fraction of these have been cloned and functionally tested. The widespread tissue distribution of ion channels, coupled with the plethora of physiological consequences of their opening and closing, makes ion-channel-targeted drug discovery highly compelling. However, despite some important drugs in clinical use today, as a class, ion channels remain underexploited in drug discovery and many existing drugs are poorly selective with significant toxicities or suboptimal efficacy. This Perspective seeks to review the ion channel family, its structural and functional features, and the diseases that are known to be modulated by members of the family. In particular, we will explore the structure and properties of known ligands and consider the future prospects for drug discovery in this challenging but high potential area.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23121096     DOI: 10.1021/jm3011433

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  93 in total

Review 1.  Bacterial voltage-gated sodium channels (BacNa(V)s) from the soil, sea, and salt lakes enlighten molecular mechanisms of electrical signaling and pharmacology in the brain and heart.

Authors:  Jian Payandeh; Daniel L Minor
Journal:  J Mol Biol       Date:  2014-08-23       Impact factor: 5.469

Review 2.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

3.  Native MS Analysis of Bacteriorhodopsin and an Empty Nanodisc by Orthogonal Acceleration Time-of-Flight, Orbitrap and Ion Cyclotron Resonance.

Authors:  Iain D G Campuzano; Huilin Li; Dhanashri Bagal; Jennifer L Lippens; Juraj Svitel; Robert J M Kurzeja; Han Xu; Paul D Schnier; Joseph A Loo
Journal:  Anal Chem       Date:  2016-12-01       Impact factor: 6.986

4.  Maxwell-Hall access resistance in graphene nanopores.

Authors:  Subin Sahu; Michael Zwolak
Journal:  Phys Chem Chem Phys       Date:  2018-02-14       Impact factor: 3.676

5.  Development and Testing of Druglike Screening Libraries.

Authors:  Junmei Wang; Yubin Ge; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-01-03       Impact factor: 4.956

6.  The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics.

Authors:  D C Pryde; N A Swain; P A Stupple; C W West; B Marron; C J Markworth; D Printzenhoff; Z Lin; P J Cox; R Suzuki; S McMurray; G J Waldron; C E Payne; J S Warmus; M L Chapman
Journal:  Medchemcomm       Date:  2017-04-28       Impact factor: 3.597

7.  In pursuit of an inhibitory drug for the proton channel.

Authors:  Amaury Pupo; Carlos Gonzalez León
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-11       Impact factor: 11.205

8.  Properties of protein drug target classes.

Authors:  Simon C Bull; Andrew J Doig
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

9.  On the role of water density fluctuations in the inhibition of a proton channel.

Authors:  Eleonora Gianti; Lucie Delemotte; Michael L Klein; Vincenzo Carnevale
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

10.  Generation of High-Specificity Antibodies against Membrane Proteins Using DNA-Gold Micronanoplexes for Gene Gun Immunization.

Authors:  Debra T Hansen; Felicia M Craciunescu; Petra Fromme; Stephen A Johnston; Kathryn F Sykes
Journal:  Curr Protoc Protein Sci       Date:  2018-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.